Soros Capital Management LLC Keros Therapeutics, Inc. Transaction History
Soros Capital Management LLC
- $536 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
172Shares Held
29.9MCall Options Held
341KPut Options Held
102K-
Black Rock Inc. New York, NY2.51MShares$25.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$19.9 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$15.5 Million7.2% of portfolio
-
State Street Corp Boston, MA1.2MShares$12.2 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.1MShares$11.2 Million0.04% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $261M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...